VISIS
Perpignan, 66000, France
Location status: Recruiting
Location contact
Boris DETHINNE, MD
CONTACT
NCT Number: NCT05561478
Prospective controlled monocentric study to determine the non-inferiority of the distance-corrected intermediate visual acuity at 66 cm of the SYNTHESIS PLUS TORIC with respect to the SYNTHESIS PLUS IOL.
Interested in participating?
Request Info50 year and older
All sexes
Observational
Perpignan, 66000, France
Location status: Recruiting
Boris DETHINNE, MD
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Non inclusion Criteria:
Exclusion criteria
Synthesis Plus IOLs are indicated for primary implantation for the visual correction of aphakia in adult patients.
Synthesis Plus Toric IOLs are indicated for primary implantation for the visual correction of aphakia in adult patients with pre-existing astigmatism.
Time frame: 1 month
The primary objective of this study is to determine the non-inferiority of the distance-corrected intermediate visual acuity at 66 cm of the SYNTHESIS PLUS TORIC with respect to the SYNTHESIS PLUS
Time frame: 1 month
distance
Time frame: 1 month
distance
Time frame: 1 month
66 cm
Time frame: 1 month
66 cm
Time frame: 1 month
subjective
Time frame: 1 month
postoperative
Time frame: Peroperatively, day 0, Month 1
in degrees
Time frame: 1 month
PROM
Contact information is provided by the study sponsor or research team.
Cutting Edge SAS
Industry
Acronym: DETPLUST
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05157113
Behavior, Cataract
San Francisco, California, United States
View Trial DetailsNCT07237061
Aromatherapy, Cataract
Singapore
View Trial DetailsNCT04130490
Cataract, Cornea Abnormality
New York, United States
View Trial DetailsNCT05610540
Behavior, Cataract
Wilkes-Barre, Pennsylvania, United States
View Trial Details